
Katherine Peebles
Examiner (ID: 14042, Phone: (571)272-6247 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 583 |
| Issued Applications | 197 |
| Pending Applications | 103 |
| Abandoned Applications | 316 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20057313
[patent_doc_number] => 20250195535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 19/065403
[patent_app_country] => US
[patent_app_date] => 2025-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19065403
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/065403 | PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM | Feb 26, 2025 | Pending |
Array
(
[id] => 19331233
[patent_doc_number] => 20240245663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => COMPACTABLE ORAL FORMULATIONS OF IBUTAMOREN
[patent_app_type] => utility
[patent_app_number] => 18/623761
[patent_app_country] => US
[patent_app_date] => 2024-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18623761
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/623761 | Compactable oral formulations of ibutamoren | Mar 31, 2024 | Issued |
Array
(
[id] => 19830829
[patent_doc_number] => 20250082615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => SOLID DISPERSION OF RIFAXIMIN
[patent_app_type] => utility
[patent_app_number] => 18/613017
[patent_app_country] => US
[patent_app_date] => 2024-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613017
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/613017 | SOLID DISPERSION OF RIFAXIMIN | Mar 20, 2024 | Pending |
Array
(
[id] => 19903066
[patent_doc_number] => 12280050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Therapeutic compositions, combinations, and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/416354
[patent_app_country] => US
[patent_app_date] => 2024-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9160
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18416354
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/416354 | Therapeutic compositions, combinations, and methods of use | Jan 17, 2024 | Issued |
Array
(
[id] => 19140421
[patent_doc_number] => 20240139204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 18/542163
[patent_app_country] => US
[patent_app_date] => 2023-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18542163
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/542163 | Pharmaceutical liquid compositions of meloxicam | Dec 14, 2023 | Issued |
Array
(
[id] => 19111327
[patent_doc_number] => 20240123077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => PACLITAXEL-HYALURONIC ACID CONJUGATE IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 18/539827
[patent_app_country] => US
[patent_app_date] => 2023-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18539827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/539827 | PACLITAXEL-HYALURONIC ACID CONJUGATE IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER | Dec 13, 2023 | Pending |
Array
(
[id] => 19599481
[patent_doc_number] => 20240390361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
[patent_app_type] => utility
[patent_app_number] => 18/533726
[patent_app_country] => US
[patent_app_date] => 2023-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18533726
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/533726 | NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE | Dec 7, 2023 | Pending |
Array
(
[id] => 19599481
[patent_doc_number] => 20240390361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE
[patent_app_type] => utility
[patent_app_number] => 18/533726
[patent_app_country] => US
[patent_app_date] => 2023-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18533726
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/533726 | NEW ABUSE-RESISTANT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OPIOID DEPENDENCE | Dec 7, 2023 | Pending |
Array
(
[id] => 18969635
[patent_doc_number] => 20240049727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => Biostimulant and method for stimulating plant growth
[patent_app_type] => utility
[patent_app_number] => 18/494791
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494791
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/494791 | Biostimulant and method for stimulating plant growth | Oct 25, 2023 | Pending |
Array
(
[id] => 18969636
[patent_doc_number] => 20240049728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => BIOSTIMULANT AND METHOD FOR STIMULATING PLANT RESISTANCE TO WATER STRESS
[patent_app_type] => utility
[patent_app_number] => 18/494842
[patent_app_country] => US
[patent_app_date] => 2023-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18494842
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/494842 | BIOSTIMULANT AND METHOD FOR STIMULATING PLANT RESISTANCE TO WATER STRESS | Oct 25, 2023 | Pending |
Array
(
[id] => 19890218
[patent_doc_number] => 20250115530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => MANGANESE ZINC SPINEL FERRITE (Mn0.5Zn0.5Fe2O4) NANOPARTICLES FOR THE GROWTH PROMOTION OF PLANTS
[patent_app_type] => utility
[patent_app_number] => 18/480993
[patent_app_country] => US
[patent_app_date] => 2023-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18480993
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/480993 | MANGANESE ZINC SPINEL FERRITE (Mn0.5Zn0.5Fe2O4) NANOPARTICLES FOR THE GROWTH PROMOTION OF PLANTS | Oct 3, 2023 | Pending |
Array
(
[id] => 19875730
[patent_doc_number] => 20250107987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => NAIL POLISH COMPOSITION CONTAINING PIPERIDINOL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/478091
[patent_app_country] => US
[patent_app_date] => 2023-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18478091
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/478091 | NAIL POLISH COMPOSITION CONTAINING PIPERIDINOL COMPOUND | Sep 28, 2023 | Pending |
Array
(
[id] => 19875730
[patent_doc_number] => 20250107987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-03
[patent_title] => NAIL POLISH COMPOSITION CONTAINING PIPERIDINOL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/478091
[patent_app_country] => US
[patent_app_date] => 2023-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18478091
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/478091 | NAIL POLISH COMPOSITION CONTAINING PIPERIDINOL COMPOUND | Sep 28, 2023 | Pending |
Array
(
[id] => 19049195
[patent_doc_number] => 20240091164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SURFACE COATING PPSU NANOPARTICLES FOR THERAPEUTIC MODULATION OF MAST CELLS
[patent_app_type] => utility
[patent_app_number] => 18/464127
[patent_app_country] => US
[patent_app_date] => 2023-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18464127
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/464127 | SURFACE COATING PPSU NANOPARTICLES FOR THERAPEUTIC MODULATION OF MAST CELLS | Sep 7, 2023 | Pending |
Array
(
[id] => 18829608
[patent_doc_number] => 20230398132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/238303
[patent_app_country] => US
[patent_app_date] => 2023-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18238303
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/238303 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | Aug 24, 2023 | Abandoned |
Array
(
[id] => 18815876
[patent_doc_number] => 20230390215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => SYSTEMS, DEVICES, AND FORMULATIONS FOR TIME-PHASED HISTAMINE DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/451361
[patent_app_country] => US
[patent_app_date] => 2023-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18451361
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/451361 | SYSTEMS, DEVICES, AND FORMULATIONS FOR TIME-PHASED HISTAMINE DELIVERY | Aug 16, 2023 | Pending |
Array
(
[id] => 18815979
[patent_doc_number] => 20230390318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => Antiviral Prodrugs and Pharmaceutical Compositions Thereof
[patent_app_type] => utility
[patent_app_number] => 18/233959
[patent_app_country] => US
[patent_app_date] => 2023-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18233959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/233959 | Antiviral Prodrugs and Pharmaceutical Compositions Thereof | Aug 14, 2023 | Abandoned |
Array
(
[id] => 18806858
[patent_doc_number] => 20230381191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => FORMULATIONS OF VILOXAZINE
[patent_app_type] => utility
[patent_app_number] => 18/232716
[patent_app_country] => US
[patent_app_date] => 2023-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18232716
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/232716 | FORMULATIONS OF VILOXAZINE | Aug 9, 2023 | Abandoned |
Array
(
[id] => 18842502
[patent_doc_number] => 20230404906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => Antipsychotic Injectable Depot Composition
[patent_app_type] => utility
[patent_app_number] => 18/366400
[patent_app_country] => US
[patent_app_date] => 2023-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18366400
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/366400 | Antipsychotic Injectable Depot Composition | Aug 6, 2023 | Pending |
Array
(
[id] => 18769293
[patent_doc_number] => 20230364050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/225397
[patent_app_country] => US
[patent_app_date] => 2023-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18225397
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/225397 | METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOF | Jul 23, 2023 | Pending |